Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lan Wei

Showing results (461-470 of 501) with videos related to

Pageof 51
Sort By:
Translational Neurodegeneration|November 13, 2025
Transplantation of hiPSC-derived pericytes rescues Alzheimer's disease phenotypes in APOE4/4 mice through IGF2-rich apoptotic vesiclesChuanfeng Xiong, Yao Tang, Junhua Chen, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 27, 2022
Association Between Baseline C-Reactive Protein and the Risk of Lung Cancer: A Prospective Population-Based Cohort StudyJian Yin, Gang Wang, Zheng Wu, et al.
Lung Cancer (Amsterdam, Netherlands)|December 11, 2021
A risk prediction model for selecting high-risk population for computed tomography lung cancer screening in ChinaLan-Wei Guo, Zhang-Yan Lyu, Qing-Cheng Meng, et al.
Frontiers in Immunology|November 4, 2021
Generation and Effect Testing of a SARS-CoV-2 RBD-Targeted Polyclonal Therapeutic Antibody Based on a 2-D Airway Organoid Screening SystemYunjiao He, Jing Qu, Lan Wei, et al.
American Journal of Respiratory Cell and Molecular Biology|January 5, 2019
STAT3 Regulates the Onset of Oxidant-induced Senescence in Lung FibroblastsDavid W Waters, Kaj E C Blokland, Prabuddha S Pathinayake, et al.
Bioorganic & Medicinal Chemistry Letters|December 8, 2005
Discovery of potent, selective, and orally bioavailable pyridone-based dipeptidyl peptidase-4 inhibitorsJinyou Xu, Lan Wei, Robert Mathvink, et al.
Frontiers in Pharmacology|February 4, 2021
Pharmacoeconomic Evaluation of Cancer Biosimilars Worldwide: A Systematic ReviewHui-Yao Huang, Cheng-Cheng Liu, Yue Yu, et al.
Dermatology and Therapy|January 13, 2022
Deucravacitinib in Moderate to Severe Psoriasis: Clinical and Quality-of-Life Outcomes in a Phase 2 TrialDiamant Thaçi, Bruce Strober, Kenneth B Gordon, et al.
Annals of Translational Medicine|September 16, 2022
Time-trend of the incidence and mortality of esophageal cancer from 2010 to 2018 and its statistics in 2018 in Henan, ChinaJian-Gong Zhang, Hui-Fang Xu, Qiong Chen, et al.
Annals of Translational Medicine|October 21, 2022
A cluster randomized controlled trial to evaluate the efficacy of esophageal and gastric cancer screening in mortality reduction in a non-high-incidence area: methodology and initial resultsXiao-Yang Wang, Shu-Zheng Liu, Hui-Fang Xu, et al.
Pageof 51

Showing results (461-470 of 501) with videos related to

Sort By:
Pageof 51
Translational Neurodegeneration|November 13, 2025
Transplantation of hiPSC-derived pericytes rescues Alzheimer's disease phenotypes in APOE4/4 mice through IGF2-rich apoptotic vesiclesChuanfeng Xiong, Yao Tang, Junhua Chen, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 27, 2022
Association Between Baseline C-Reactive Protein and the Risk of Lung Cancer: A Prospective Population-Based Cohort StudyJian Yin, Gang Wang, Zheng Wu, et al.
Lung Cancer (Amsterdam, Netherlands)|December 11, 2021
A risk prediction model for selecting high-risk population for computed tomography lung cancer screening in ChinaLan-Wei Guo, Zhang-Yan Lyu, Qing-Cheng Meng, et al.
Frontiers in Immunology|November 4, 2021
Generation and Effect Testing of a SARS-CoV-2 RBD-Targeted Polyclonal Therapeutic Antibody Based on a 2-D Airway Organoid Screening SystemYunjiao He, Jing Qu, Lan Wei, et al.
American Journal of Respiratory Cell and Molecular Biology|January 5, 2019
STAT3 Regulates the Onset of Oxidant-induced Senescence in Lung FibroblastsDavid W Waters, Kaj E C Blokland, Prabuddha S Pathinayake, et al.
Bioorganic & Medicinal Chemistry Letters|December 8, 2005
Discovery of potent, selective, and orally bioavailable pyridone-based dipeptidyl peptidase-4 inhibitorsJinyou Xu, Lan Wei, Robert Mathvink, et al.
Frontiers in Pharmacology|February 4, 2021
Pharmacoeconomic Evaluation of Cancer Biosimilars Worldwide: A Systematic ReviewHui-Yao Huang, Cheng-Cheng Liu, Yue Yu, et al.
Dermatology and Therapy|January 13, 2022
Deucravacitinib in Moderate to Severe Psoriasis: Clinical and Quality-of-Life Outcomes in a Phase 2 TrialDiamant Thaçi, Bruce Strober, Kenneth B Gordon, et al.
Annals of Translational Medicine|September 16, 2022
Time-trend of the incidence and mortality of esophageal cancer from 2010 to 2018 and its statistics in 2018 in Henan, ChinaJian-Gong Zhang, Hui-Fang Xu, Qiong Chen, et al.
Annals of Translational Medicine|October 21, 2022
A cluster randomized controlled trial to evaluate the efficacy of esophageal and gastric cancer screening in mortality reduction in a non-high-incidence area: methodology and initial resultsXiao-Yang Wang, Shu-Zheng Liu, Hui-Fang Xu, et al.
Pageof 51